Nuflor Minidose Data Sheet
A clear colourless to yellow solution for injection containing 450 mg/ml florfenicol.
Preventive and therapeutic treatment of respiratory tract infections in cattle due to Mannheimia haemolytica, Pasteurella multocida and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.
Dosage and administration
Subcutaneous route: 40 mg/kg body weight (4 ml/45 kg) to be administered once only.
Intramuscular route: 20 mg/kg body weight (2 ml/45 kg) to be administered twice 48 hours apart.
The injection should only be given in the neck. The dose volume given at any one injection site should not exceed 10 ml.
To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
Swab septum before removing each dose. Use a dry, sterile needle and syringe.
For 250 ml vials, do not broach the vial more than 25 times.
Contra-indications, warnings, etc
Not for use in adult bulls intended for breeding purposes.
Studies in laboratory animals have not revealed any evidence of embryo- or foetotoxic potential for florfenicol.
However, the effect of florfenicol on bovine reproductive performance and pregnancy has not been assessed.
Use only according to the benefit/risk assessment by the responsible veterinarian.
The product should be used in conjunction with susceptibility testing and take into account official and local antimicrobial policies.
A decrease in food consumption and transient softening of the faeces may occur during the treatment period. The treated animals recover quickly and completely upon termination of treatment.
Subcutaneous injection of the product at the maximum recommended volume of 10 ml per injection site may cause transient local algesia and clinically obvious swelling at the injection site. Local algesia may persist for some days. Injection site swellings decrease over time but may persist for up to 61 days.
Intramuscular injection of the product at the maximum recommended volume of 10 ml per injection site may
cause transient local algesia and clinically obvious swelling at the injection site. Local algesia may persist for
some days. Injection site swellings decrease over time but may persist for up to 24 days. Inflammatory lesions
at the injection site (seen at necropsy) may persist for 37 days after injection.
Care should be taken to avoid accidental self-injection. In case of self-injection, seek medical advice
immediately and show the package leaflet or the label to the physician. Avoid direct contact with skin, mouth
and eyes. Wash hands after treatment.
For animal treatment only. Keep out of the reach and sight of children.
Meat and offal:
by SC (at 40 mg/kg body weight, once): 64 days.
by IM (at 20 mg/kg body weight, twice): 37 days.
Not permitted for use in lactating animals producing milk for human consumption.
This veterinary medicinal product does not require any special storage conditions.
Keep the vial in the outer carton in order to protect from light.
Shelf-life after first opening the immediate packaging: 28 days.
Dispose of any unused product and empty containers in accordance with guidance from your local waste
50, 100 and 250 ml colourless type II glass multiple dose vials, sealed with bromobutyl rubber stoppers. Not all
pack sizes may be marketed.
Marketing authorisation number